- Home
- APLT vs ALAR Comparison
APLT vs ALAR Comparison
Compare APLT & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- ALAR
- Stock Information
- Founded
- APLT 2016
- ALAR 2013
- Country
- APLT United States
- ALAR Israel
- Employees
- APLT N/A
- ALAR N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- ALAR Computer Software: Prepackaged Software
- Sector
- APLT Health Care
- ALAR Technology
- Exchange
- APLT Nasdaq
- ALAR Nasdaq
- Market Cap
- APLT 37.5M
- ALAR 41.3M
- IPO Year
- APLT 2019
- ALAR 2018
- Fundamental
- Price
- APLT $0.41
- ALAR $6.93
- Analyst Decision
- APLT Buy
- ALAR Strong Buy
- Analyst Count
- APLT 7
- ALAR 1
- Target Price
- APLT $6.10
- ALAR $11.00
- AVG Volume (30 Days)
- APLT 1.9M
- ALAR 86.2K
- Earning Date
- APLT 05-20-2025
- ALAR 05-29-2025
- Dividend Yield
- APLT N/A
- ALAR N/A
- EPS Growth
- APLT N/A
- ALAR N/A
- EPS
- APLT N/A
- ALAR 0.08
- Revenue
- APLT $455,000.00
- ALAR $31,824,000.00
- Revenue This Year
- APLT $1,768.13
- ALAR N/A
- Revenue Next Year
- APLT $361.28
- ALAR $12.28
- P/E Ratio
- APLT N/A
- ALAR $8.15
- Revenue Growth
- APLT N/A
- ALAR 20.00
- 52 Week Low
- APLT $0.30
- ALAR $5.45
- 52 Week High
- APLT $10.62
- ALAR $46.69
- Technical
- Relative Strength Index (RSI)
- APLT 48.67
- ALAR 49.92
- Support Level
- APLT $0.39
- ALAR $6.31
- Resistance Level
- APLT $0.49
- ALAR $7.30
- Average True Range (ATR)
- APLT 0.04
- ALAR 0.46
- MACD
- APLT 0.01
- ALAR -0.03
- Stochastic Oscillator
- APLT 55.40
- ALAR 41.89
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.